Insider Trading activities of Cutera Inc insiders. , Part 2

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Cutera Inc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Cutera Inc since year 2005. (See page 1 of this report.) Table 2 shows the detailed insider transactions of Cutera Inc since 2005. The reporting company's ticker symbol is CUTR. The reporting company's CIK number is 1162461.
The total value of stock buying since 2005 is $287,295.
The total value of stock sales since 2005 is $58,652,408.
The total value of stock option exercises since 2005 is $7,939,721.


 1   2 

Table 2. Detailed insider stock purchases, sales, and option exercises of Cutera Inc insiders (CUTR) , Part 2
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2012-08-24 Oshea Timothy J Sale 1,000 7.39 7,390
2012-08-23 Oshea Timothy J Sale 1,100 7.42 8,164
2012-08-22 Oshea Timothy J Sale 1,600 7.52 12,036
2012-08-21 Connors Kevin P (President and CEO) Buy 7,000 7.35 51,450
2012-08-20 Connors Kevin P (President and CEO) Buy 5,000 7.22 36,080
2012-03-15 Santilli Ronald J (EVP and CFO) Sale 3,372 9.06 30,567
2012-02-17 Oshea Timothy J Sale 1,750 9.27 16,224
2011-09-23 Santilli Ronald J (EVP and CFO) Sale 5,000 7.04 35,220
2011-09-23 Santilli Ronald J (EVP and CFO) Option Ex 5,000 5.50 27,500
2011-09-22 Santilli Ronald J (EVP and CFO) Sale 5,000 7.08 35,395
2011-09-22 Santilli Ronald J (EVP and CFO) Option Ex 5,000 5.50 27,500
2011-09-21 Santilli Ronald J (EVP and CFO) Sale 5,000 7.30 36,490
2011-09-21 Santilli Ronald J (EVP and CFO) Option Ex 5,000 5.50 27,500
2011-09-20 Santilli Ronald J (EVP and CFO) Sale 5,000 7.29 36,465
2011-09-20 Santilli Ronald J (EVP and CFO) Option Ex 5,000 5.50 27,500
2011-06-06 Connors Kevin P (President and CEO) Option Ex 40,000 2.50 100,000
2010-08-03 Connors Kevin P (President and CEO) Option Ex 50,000 .50 25,000
2010-05-14 Apfelberg David B (Director) Sale 7,308 9.82 71,793
2009-02-06 Connors Kevin P (President and CEO) Option Ex 408,333 .10 40,833
2009-01-06 Gollnick David A (VP of Research and Development) Option Ex 73,400 1.03 75,822
2007-12-27 Connors Kevin P (President and CEO) Sale 37,500 15.22 570,825
2007-12-27 Gollnick David A (VP of Research and Development) Sale 60,000 15.22 913,500
2007-12-21 Connors Kevin P (President and CEO) Sale 37,500 14.90 558,937
2007-12-14 Connors Kevin P (President and CEO) Sale 37,500 15.02 563,250
2007-12-07 Connors Kevin P (President and CEO) Sale 37,500 16.72 627,075
2007-10-23 Gollnick David A (VP of Research and Development) Sale 30,000 24.46 733,770
2007-10-22 Gollnick David A (VP of Research and Development) Sale 30,000 24.11 723,420
2007-08-20 Connors Kevin P (President and CEO) Option Ex 65,000 .10 6,500
2007-05-10 Gollnick David A (VP of Research and Development) Option Ex 60,000 .10 6,000
2007-02-28 Connors Kevin P (President and CEO) Option Ex 150,000 .10 15,000
2007-02-27 Connors John (VP of North American Sales) Sale 7,500 36.69 275,137
2007-02-27 Connors John (VP of North American Sales) Option Ex 7,500 .75 5,625
2007-02-23 Gollnick David A (VP of Research and Development) Sale 35,000 37.23 1,302,910
2007-02-23 Gollnick David A (VP of Research and Development) Option Ex 35,000 .10 3,500
2007-02-22 Connors Kevin P (President and CEO) Sale 100,000 37.12 3,712,200
2007-02-22 Connors Kevin P (President and CEO) Option Ex 100,000 1.28 128,499
2007-02-21 Shine Robert John Jr (VP of International) Sale 3,000 37.35 112,053
2007-02-21 Shine Robert John Jr (VP of International) Option Ex 3,000 4.25 12,750
2007-02-20 Santilli Ronald J (CFO & VP of Finance and Admin.) Sale 10,000 37.06 370,570
2007-02-20 Santilli Ronald J (CFO & VP of Finance and Admin.) Option Ex 10,000 5.50 55,000
2007-02-09 Apfelberg David B (Director) Option Ex 20,000 4.25 85,000
2007-02-08 Santilli Ronald J (CFO & VP of Finance and Admin.) Sale 10,000 35.00 350,000
2007-02-08 Santilli Ronald J (CFO & VP of Finance and Admin.) Option Ex 10,000 5.50 55,000
2007-02-08 Gollnick David A (VP of Research and Development) Option Ex 60,000 .10 6,000
2006-11-28 Connors John (VP of North American Sales) Sale 9,917 27.61 273,788
2006-11-28 Connors John (VP of North American Sales) Option Ex 9,917 .27 2,637
2006-11-14 Oshea Timothy J (Director) Sale 5,000 28.40 142,000
2006-11-14 Oshea Timothy J (Director) Option Ex 5,000 14.14 70,700
2006-11-14 Santilli Ronald J (CFO & VP of Finance and Admin.) Sale 5,000 28.40 142,000
2006-11-14 Santilli Ronald J (CFO & VP of Finance and Admin.) Option Ex 5,000 5.50 27,500
2006-11-13 Santilli Ronald J (CFO & VP of Finance and Admin.) Sale 5,000 28.30 141,500
2006-11-13 Santilli Ronald J (CFO & VP of Finance and Admin.) Option Ex 5,000 5.50 27,500
2006-11-10 Gollnick David A (VP of Research and Development) Sale 33,183 28.05 930,882
2006-11-10 Gollnick David A (VP of Research and Development) Option Ex 33,183 11.09 368,032
2006-11-09 Shine Robert John Jr (VP of International) Sale 5,000 28.28 141,415
2006-11-09 Shine Robert John Jr (VP of International) Option Ex 5,000 4.25 21,250
2006-11-09 Gollnick David A (VP of Research and Development) Sale 21,191 28.55 605,024
2006-11-09 Gollnick David A (VP of Research and Development) Option Ex 18,380 4.25 78,115
2006-08-31 Connors John (VP of North American Sales) Sale 8,083 23.20 187,559
2006-08-29 Oshea Timothy J (Director) Sale 5,000 23.15 115,755
2006-08-29 Oshea Timothy J (Director) Option Ex 5,000 14.14 70,700
2006-08-24 Santilli Ronald J (CFO & VP of Finance and Admin.) Sale 3,780 25.13 94,980
2006-08-24 Santilli Ronald J (CFO & VP of Finance and Admin.) Option Ex 3,780 4.25 16,065
2006-08-23 Santilli Ronald J (CFO & VP of Finance and Admin.) Sale 6,220 25.18 156,625
2006-08-23 Santilli Ronald J (CFO & VP of Finance and Admin.) Option Ex 6,220 4.25 26,435
2006-08-11 Gollnick David A (VP of Research and Development) Sale 20,000 24.10 480,972
2006-08-10 Gollnick David A (VP of Research and Development) Sale 44,700 23.82 1,067,453
2006-06-20 Gollnick David A (VP of Research and Development) Option Ex 100,000 .10 10,000
2006-02-17 Campbell White Annette (Director) Buy 3,000 25.50 76,500
2006-02-16 Campbell White Annette (Director) Buy 2,000 24.81 49,620
2005-11-23 Liolios Thomas John (VP of International) Sale 742 39.41 29,242
2005-11-17 Connors John (VP of North American) Sale 10,000 38.20 382,050
2005-11-08 Connors Kevin P (President and CEO) Sale 70,232 34.97 2,455,872
2005-11-08 Gollnick David A (VP of Research and D) Sale 59,007 35.33 2,084,599
2005-11-07 Connors Kevin P (President and CEO) Sale 107,500 35.18 3,776,751
2005-11-07 Gollnick David A (VP of Research and D) Sale 67,500 35.00 2,362,432
2005-11-04 Apfelberg David B (Director) Sale 20,000 33.53 670,699
2005-08-25 Connors John (VP of North American) Sale 7,000 23.10 161,686
2005-08-24 Connors John (VP of North American) Sale 3,000 22.81 68,421
2005-08-18 Connors Kevin P (President and CEO) Sale 5,000 21.08 105,399
2005-08-15 Nohra Guy P (Director) Sale 1,737 23.33 40,524
2005-08-11 Connors Kevin P (President and CEO) Sale 5,000 21.87 109,350
2005-08-04 Connors Kevin P (President and CEO) Sale 5,000 21.99 109,949
2005-08-04 Apfelberg David B (Director) Sale 5,000 22.00 110,000
2005-08-03 Connors Kevin P (President and CEO) Sale 15,000 22.29 334,335
2005-07-28 Connors Kevin P (President and CEO) Sale 5,000 18.50 92,500
2005-07-25 Connors Kevin P (President and CEO) Sale 5,000 18.48 92,400
2005-07-11 Levernier Michael J (VP of Clinical Devel) Sale 3,300 16.56 54,654
2005-07-05 Levernier Michael J (VP of Clinical Devel) Sale 3,300 16.90 55,763
2005-06-27 Levernier Michael J (VP of Clinical Devel) Sale 3,300 17.70 58,410
2005-06-22 Gollnick David A (VP of Research and D) Sale 2,000 17.88 35,760
2005-06-20 Levernier Michael J (VP of Clinical Devel) Sale 3,300 16.25 53,608
2005-06-15 Gollnick David A (VP of Research and D) Sale 4,000 16.25 65,004
2005-06-13 Levernier Michael J (VP of Clinical Devel) Sale 3,300 15.37 50,730
2005-06-08 Gollnick David A (VP of Research and D) Sale 4,000 14.75 59,000
2005-06-06 Levernier Michael J (VP of Clinical Devel) Sale 3,300 15.33 50,589
2005-06-01 Gollnick David A (VP of Research and D) Sale 4,000 15.69 62,776
2005-05-31 Connors John (VP of North American) Sale 15,000 16.13 241,935
2005-05-31 Levernier Michael J (VP of Clinical Devel) Sale 6,600 15.36 101,342
2005-05-25 Campbell White Annette (Director) Buy 5,000 14.73 73,645
2005-05-25 Gollnick David A (VP of Research and D) Sale 4,000 14.93 59,728
2005-05-23 Levernier Michael J (VP of Clinical Devel) Sale 3,300 15.20 50,169
2005-05-18 Gollnick David A (VP of Research and D) Sale 4,000 15.23 60,932
2005-05-16 Levernier Michael J (VP of Clinical Devel) Sale 3,300 15.59 51,430
2005-05-11 Gollnick David A (VP of Research and D) Sale 4,000 15.65 62,596
2005-05-09 Levernier Michael J (VP of Clinical Devel) Sale 3,300 16.52 54,512
2005-05-04 Gollnick David A (VP of Research and D) Sale 4,000 17.71 70,840
2005-05-02 Levernier Michael J (VP of Clinical Devel) Sale 2,000 16.85 33,700
2005-04-27 Gollnick David A (VP of Research and D) Sale 4,000 17.06 68,232
2005-04-25 Levernier Michael J (VP of Clinical Devel) Sale 2,000 17.77 35,540
2005-04-21 Connors Kevin P (President and CEO) Sale 5,000 17.28 86,410
2005-04-20 Gollnick David A (VP of Research and D) Sale 4,000 17.59 70,360
2005-04-18 Levernier Michael J (VP of Clinical Devel) Sale 2,000 17.25 34,500
2005-04-14 Connors Kevin P (President and CEO) Sale 5,000 18.01 90,040
2005-04-13 Gollnick David A (VP of Research and D) Sale 4,000 18.93 75,720
2005-04-11 Levernier Michael J (VP of Clinical Devel) Sale 2,000 19.60 39,200
2005-04-07 Connors Kevin P (President and CEO) Sale 5,000 19.23 96,150
2005-04-06 Gollnick David A (VP of Research and D) Sale 4,000 18.48 73,904
2005-03-31 Connors Kevin P (President and CEO) Sale 5,000 19.08 95,385
2005-03-30 Gollnick David A (VP of Research and D) Sale 4,000 19.02 76,100
2005-03-28 Levernier Michael J (VP of Clinical Devel) Sale 2,000 18.99 37,980
2005-03-24 Connors Kevin P (President and CEO) Sale 5,000 18.40 91,984
2005-03-23 Gollnick David A (VP of Research and D) Sale 2,000 18.48 36,960
2005-03-21 Levernier Michael J (VP of Clinical Devel) Sale 2,000 17.41 34,830
2005-03-17 Connors Kevin P (President and CEO) Sale 5,000 18.56 92,815
2005-03-16 Gollnick David A (VP of Research and D) Sale 2,000 18.77 37,540
2005-03-14 Levernier Michael J (VP of Clinical Devel) Sale 2,000 18.68 37,352
2005-03-10 Connors Kevin P (President and CEO) Sale 5,000 17.75 88,730
2005-03-09 Gollnick David A (VP of Research and D) Sale 2,000 17.34 34,670
 1   2 

Insider trading activities including stock purchases, stock sales, and option exercises of CUTR listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Cutera Inc (symbol CUTR, CIK number 1162461) see the Securities and Exchange Commission (SEC) website.